Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased or otherwise acquired ARS Pharmaceuticals Inc. (ARS Pharm. or the “Company”) (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026, inclusive (the “Class Period”).